Recent Comments
- Charles Carroll on Daily Alcohol is Not OK
- Charles Carroll on A food-borne illness mystery and what is wrong with current medical schools
- Is Italian flour healthier than American? | Quality of Life Clinic on Celiac disease is not reduced by breast feeding or delaying the introduction of gluten
- LB on The final House report on COVID
- Joy Smith on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (34,905)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (21,762)
- The Healthcare Channel hits 10 (19,431)
- New treatment paradigm for C. Diff colitis (18,052)
- How the FDA regulates compounding pharmacies (17,418)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (17,282)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (16,971)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (15,241)
- The new CDC guidelines for prescribing opioid pain pills (13,574)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (13,285)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Otolaryngology
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Wellness and Prevention
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Author Archives: admin
CBS allows TV doctor to make egregious claims about statins
Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading
Posted in - Pharma, Cardiology, Cedars Sinai
Leave a comment
The finances of TAVI: do prices have to come down?
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses … Continue reading
Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS
Leave a comment
TAVI: Comparing CoreValve to Sapien
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
New therapies for hepatitis C
November 6, 2013- Interviewed by Steven E. Greer, MD In Part 1, Sammy Saab, MD, MPH, liver disease and GI doctor from UCLA, discusses the standard of care
The clinical hurdles to prescribing CGM
October 31, 2014– Interviewed by Steven E. Greer, MD The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM)
Did the GOP shut down the government just to please a special interest industry lobby?
October 19, 2013- By Steven E. Greer MD The United States government was partially shut down for more than two weeks in October.
Posted in - Medical Devices, - Opinion, Congress
Leave a comment
The more we know, the more unnecessary President Bush’s stent seems
October 16, 2013 By Steven E. Greer, MD A recent short article in an obscure Washington, DC wonky journal triggered national media
Posted in Cardiac surgery, Cardiology
Leave a comment
Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.
October 23, 2013- Interviewed by Steven E. Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer.
A Bridge Too Far: Patient classifications for LVAD reimbursement
September 16, 2013- By Ashish Shah, MD, Cardiac transplant surgeon, The Johns Hopkins Medical Center Left ventricular assist devices (LVADs) arose from the ashes of the total artificial heart era.
Posted in - Opinion, Cardiac surgery, CMS, Johns Hopkins
Leave a comment
Little guy challenges Dr. Oz over copyright infringement and wins
September 12, 2013- By Steven E. Greer, MD Under certain circumstances, copyrighted text or video content can be used by others without
Posted in - Opinion, Cardiac surgery, Congress
Leave a comment
Super rapid acting insulin and inhaled insulin
September 9, 2013- Interviewed by Steven E. Greer, MD Jay Skyler, MD, PhD, Deputy Director of the Diabetes Research Institute at The University
Posted in - Biotech, - Pharma, Diabetes and endocrinology, Univ Miami
Leave a comment
Exclusive: President Bush had controversial coronary CT-scan as routine screening leading to questionable stent
August 7, 2013- By Steven E. Greer, MD The press has reported extensively about President George W. Bush (The 43rd President) receiving a controversial coronary stent after a routine annual exam found a blockage in an
Posted in Uncategorized
Leave a comment
Serelaxin to treat acute heart failure
July 8, 2013- The FDA granted Novartis the coveted “Breakthrough” status for drug serelaxin
Posted in Cardiology, UCLA
Leave a comment
The Yale led reanalysis of the BMP-2 InFuse trials
June 20, 2013- Interviewed by Steven E. Greer, MD Medtronic granted rare access to a team led my Yale’s Harlan Krumholz and turned over the complete
Posted in Orthopedic surgery, Yale
Leave a comment
Exclusive: CEO of Komen for the Cure never stepped down as announced in 2012
June 6, 2013- By Steven E. Greer, MD The breast cancer research foundation Komen for the Cure, founded by Nancy Brinker, got into hot water in 2012
Posted in - Policy, Oncology
Leave a comment
FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs
Interviewed by Steven E. Greer, MD
Posted in - Pharma, FDA
Leave a comment
What happens next with the ACA law?
May 20, 2013- Interviewed by Steven E. Greer, MD
Posted in CMS, Congress
Leave a comment
Reasons for permanent slowdowns in healthcare spending growth
May 17, 2013- Interviewed by Steven E. Greer, MD Since 2010,
Posted in CMS, Harvard
Leave a comment
Bioabsorbable stents
May 14, 2013- William O’Neill, MD of Henry Ford discusses bioabsorbable coronary stents, and the U.S. Abbott trials.
Posted in Cardiac surgery, Cardiology, Henry Ford
Leave a comment